The online-only Data Supplement is available at http://circep.ahajournals.org/lookup/suppl/Background-We examined the hypothesis that leptin signaling contributes to the atrial fibrosis and atrial fibrillation (AF) evoked by angiotensin II (AngII). Methods and Results-Eight-week-old male CL57/B6 (CNT) and leptin-deficient ob/ob mice (Ob) were subcutaneously infused with AngII (2.0 mg/kg per day). Two weeks later, transesophageal burst pacing and an electrophysiological study using isolated perfused hearts were performed. Left-atrial tissues were collected to determine interstitial fibrosis by Masson trichrome staining, and the expressions of mRNAs related to inflammatory profibrotic signals were assessed. Left-atrial fibroblasts were isolated from adult Sprague-Dawley and Zucker rats. The effects of leptin (100 ng/mL) or AngII (100 nmol/L) treatment were evaluated. In CNT-AngII mice, leptin expression in the left atrium was upregulated (P<0.01).
A trial fibrillation (AF) is the most common sustained arrhythmia seen in the clinical setting and is associated with significant morbidity and mortality. 1, 2 Accumulating evidence indicates that atrial structural remodeling, especially inflammatory profibrotic signals that led to the development of interstitial atrial fibrosis, has been revealed to play a crucial role in the pathogenesis of AF. [3] [4] [5] 
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Leptin, a 16-kDa peptide hormone, which is mainly secreted by adipocytes, regulates appetite and body fat mass, predominantly through the central nervous system. [6] [7] [8] However, it has additionally been identified as a proinflammatory adipocytokine that can provoke inflammatory-mediated interstitial fibrosis in several peripheral organs. [9] [10] [11] [12] For instance, Honda et al 11 demonstrated that thioacetamide failed to trigger hepatic fibrosis in leptin-deficient ob/ob (Ob) mice. Similarly, Tanaka et al 12 demonstrated that renal macrophage infiltration and tubulointerstitial fibrosis evoked by unilateral ureteral obstruction was reduced in Ob mice. These observations led us to hypothesize that leptin signaling plays an essential role in proinflammatory atrial fibrosis. In this regard, we have demonstrated that continuous subcutaneous infusion of angiotensin II (AngII) results in interstitial atrial fibrosis and increased AF inducibility in rats. 13 We also demonstrated that AngII upregulated extracellular signal-regulated kinase 1/2 phosphorylation, α-smooth muscle actin (α-SMA) expression, transforming growth factor-β1 (TGF-β1) secretion, and collagen synthesis in cultured rat atrial fibroblasts. 13 Thus, our continuous AngII infusion AF model can be postulated to represent AF progression associated with enhanced inflammatory profibrotic signals.
In the present study, we investigated the involvement of leptin signaling in the pathogenesis of AngII-evoked inflammatory atrial fibrosis and enhanced AF vulnerability, using leptin-deficient Ob mice in vivo and ex vivo, and in vitro in rat atrial fibroblasts that contain a malfunctioning receptor for leptin receptor (the Zucker rat model).
Methods
All experimental procedures were conducted in accordance with the guidelines of the Physiological Society of Oita University, Japan, for the care and use of laboratory animals, following the guidelines established by the US National Institutes of Health. For detailed Methods, see the online-only Data Supplement.
Results

Hemodynamic Characteristics
Systolic blood pressure and heart rate measurements during the experimental period are shown in Figure I in the onlineonly Data Supplement. Before AngII infusion, no significant differences in these 2 parameters were observed between control (CNT) and Ob mice. Continuous AngII infusion caused elevation of systolic blood pressure and heart rate in both CNT-AngII and Ob-AngII mice (both P<0.01). We observed no significant differences in these 2 parameters between CNT-AngII mice and Ob-AngII mice on days 7 and 14.
Physiological and Echocardiographic Findings
The physiological and echocardiographic findings on day 14 are presented in the Table. Compared with the corresponding vehicle (VEH)-treated mice, body weights were significantly lower in the CNT-AngII mice and Ob-AngII mice (both P<0.01). However, AngII infusion led to increased heart weight in CNT-AngII mice and Ob-AngII mice compared with the corresponding VEH-treated mice (both P<0.01). The heart-to-body weight ratio was significantly greater in the CNT-AngII and Ob-AngII mice groups relative to the corresponding VEH-treated mice (both P<0.01). Echocardiographic findings revealed that AngII caused concentric hypertrophy in both CNT mice and Ob mice, characterized by a decrease in left ventricular end-diastolic diameter (LVDd) (both P<0.05) and an increase in LV enddiastolic posterior wall thickness (LVPWth) (both P<0.01). LV ejection fraction (LVEF) was not significantly influenced by AngII in either the CNT-AngII or the Ob-AngII mice groups.
Serum Parameters
Serum blood chemistry data are presented in the Table. In CNT mice, AngII did not cause significant changes in the plasma levels of glucose and insulin. In contrast, AngII infusion in Ob mice resulted in a significant decrease in plasma glucose (P<0.05) and insulin (P<0.01). As expected, plasma leptin was not detected in Ob mice. In CNT mice, AngII infusion resulted in a decreased level of plasma leptin (P<0.05). Plasma adiponectin level was not significantly different among the 4 experimental groups.
Left-Atrial Tissue Expression of Leptin
Representative immunohistochemical staining using leptin antibody is depicted in Figure 1A . Brown staining indicates leptin expression. Leptin was expressed at low levels in the CNT-VEH mouse left atrium, but was abundant in the AngII-CNT mouse left atrium. On the other hand, leptin was not observed in the Ob mouse left atrium, irrespective of AngII infusion. Figure 1B displays quantitative analysis of leptin mRNA in left-atrial tissue. Compared with CNT-VEH mice, CNT-AngII mice showed a 4.79-fold increase in leptin mRNA (P<0.01). The protein levels of leptin in the whole heart were greater in CNT-AngII mice than in CNT-VEH mice (1.7-fold; P<0.01; Figure II in the online-only Data Supplement).
Messenger RNAs Related to Profibrotic Signals
Quantitative analysis of the mRNA levels of molecules related to profibrotic and proinflammatory signals is presented in Figure 2 . Messenger RNAs of collagen 1 and collagen 3 (Figure 2A and 2B) were increased by AngII infusion, both in CNT-AngII mice (3.01-and 3.50-fold, respectively; both P<0.01) and in Ob-AngII mice (1.78-and 1.70-fold, respectively; P<0.01 and P<0.05, respectively) compared with the CNT-VEH group. Notably, mRNA expression levels were significantly lower in Ob-AngII mice than in CNT-AngII mice (P<0.05 and P<0.01, respectively). Similarly, in CNT mice, AngII induced a significant increase in the expression of TGF-β1 (1.87-fold; P<0.01), α-SMA (2.50-fold; P<0.01), F4/80 (2.23-fold; P<0.01), monocyte chemoattractant protein-1 than in CNT-AngII mice (P<0.05, P<0.01, P<0.01, P<0.01, P<0.01, respectively). The corresponding protein levels of these mRNAs isolated from whole heart in CNT mice were significantly increased in response to continuous AngII infusion, whereas such a response was significantly attenuated in Ob mice ( Figure III in the online-only Data Supplement). Figure 3A shows the representative results of Masson trichrome staining of the left atrium. The blue staining indicates interstitial fibrosis. The quantitative ratio of the area of fibrosis to the area of the reference tissue is summarized in Figure 3B . Masson trichrome staining revealed inhomogeneous interstitial fibrosis in the CNT-AngII mice left atrium (P<0.01). However, such fibrosis was not observed in the Ob-AngII mice left atrium. By quantification, interstitial fibrosis was attenuated in Ob-AngII mice compared with CNT-AngII mice (P<0.05).
Left-Atrial Interstitial Fibrosis
Hydroxyproline Assay
Figure IV in the online-only Data Supplement shows the collagen content in the left atrium as evaluated by quantification of hydroxyproline. Continuous AngII infusion significantly increased left-atrial collagen content in CNT-AngII mice (P<0.01). This increase was attenuated in Ob-AngII mice (P<0.01).
Incidence and Duration of AF by Transesophageal Burst Pacing
Representative ECG recordings before and after the transesophageal burst pacing are presented in Figure 4A . In Figure  4A , burst pacing was followed by induction of AF. AF was equally induced in 1/8 (13%) of both the CNT-VEH and the Ob-VEH groups, as shown in Figure 4B . Burst pacing induced AF in 7/8 (87%) of CNT-AngII mice (P<0.05 versus CNT-VEH), but not in Ob-AngII mice (0/8; P<0.01 versus CNT-AngII). During the AF induced in CNT-AngII mice, the mean ventricular cycle length (CL) was 172±8 ms. The analysis of AF duration is depicted in Figure 4C . The mean duration of AF was significantly longer in CNT-AngII mice compared with that in CNT-VEH mice (P<0.01).
Electrophysiological Studies Using Isolated Perfused Hearts
No significant differences were observed in left-atrial effective refractory period (ERP) among the 4 experimental groups ( Figure 5A ). When compared with the CNT-VEH and Ob-VEH groups, the interatrial conduction time (IACT) in the CNT-AngII mice was prolonged at all the basic CLs tested (P<0.01; Figure 5B ). This prolongation was suppressed in Ob-AngII mice (P<0.01 for each CL). Figure 5C shows a representative AF induced by the burst pacing, which was observed in a CNT-AngII mouse. Figure 5D shows the inducibility of AF. In the CNT-AngII group, S3 extrastimuli and burst pacing induced AF in 4/6 rats (67%). In contrast, AF was not induced at all in hearts from CNT-VEH, Ob-VEH, or Ob-AngII mice (0/6 in each group). Figure 5E illustrates the AF duration, while Figure 5F plots the atrial and ventricular CLs during AF. During the AF induced in CNT-AngII mice, the atrial and ventricular CLs were 58.3±15.3 and 244.0±39.0 ms, respectively.
Leptin Expression in Rat Atrial Fibroblasts
In Sprague-Dawley (SD) rat atrial fibroblasts, the addition of AngII (100 nmol/L) into the culture medium increased leptin expression at both the mRNA ( Figure 6A ) and protein levels ( Figure 6B ; both P<0.01).
Experiments Using Zucker Rat Atrial Fibroblasts
The distinct responses between SD and Zucker rat atrial fibroblasts to leptin (100 ng/mL) in terms of profibrotic signals are shown in Figure 7 . TGF-β1 secretion was increased by leptin in SD rat atrial fibroblasts (P<0.05; Figure 7A ). Expression of α-SMA resulted in a 1.56-fold increase in SD rat atrial fibroblasts (P<0.01; Figure 7B ). The expressions of MCP-1 by leptin also increased 2.02-fold in SD rat atrial fibroblasts (P<0.01; Figure 7C ). The expression of RANTES in response to leptin showed a 1.63-fold increase in SD rat atrial fibroblasts (P<0.01; Figure 7D ). In sharp contrast, these positive responses to leptin were lacking in atrial fibroblasts isolated from Zucker rats ( Figure 7A-7D ).
Discussion
The core findings of the present study are as follows: (1) in the mice in vivo experiments, naturally occurring leptindeficient Ob mice did not develop left-atrial interstitial fibrosis and AF inducibility in response to continuous infusion of AngII; (2) in an electrophysiological study using isolated perfused hearts, neither the high inducibility of AF nor the atrial conduction delay observed in CNT-AngII mice was observed in Ob-AngII mice; (3) left-atrial tissue isolated from CNT mice showed abundant leptin expression in response to continuous AngII infusion, which led to upregulated leptin expression in cultured SD rat atrial fibroblasts; and (4) left-atrial tissue isolated from Ob mice showed a reduced effect of AngII inflammatory profibrotic A B signal-related mRNA. Consistent with these findings, cultured atrial fibroblasts isolated from Zucker (leptin receptor malfunctioning) rats did not express molecules associated with inflammatory profibrotic signals in response to leptin treatment. The lack of these responses to AngII was also confirmed in whole heart isolated from Ob mice. To our knowledge, this is the first report to demonstrate the essential role of leptin and its receptor-mediated signaling in the pathogenesis of atrial fibrosis and AF. Enhanced local atrial expression of leptin is also suggested to play an autocrine role in AngII-induced atrial fibrosis, which is absent in Ob mice and Zucker rats. Although there is no direct evidence, the mechanisms of AF observed in CNT-AngII mice can be postulated to be reentrant because of atrial conduction A C B disturbance, which is associated with AngII-induced atrial interstitial fibrosis. The relationship between leptin signaling and fibrogenesis has been extensively investigated in the liver. [9] [10] [11] Ikejima et al 9 first demonstrated that intraperitoneal administration of leptin, administered with hepatotoxic chemicals, including carbon tetrachloride and thioacetamide, enhanced hepatic fibrosis in association with enhanced expression of α-SMA and TGF-β1. The authors concluded that upregulation of TGF-β1, leading to activation of hepatic stellate cells, is an essential leptinmediated fibrogenic response in the liver. 9 Subsequently, the same group demonstrated near-complete prevention of thioacetamide-induced hepatic fibrosis in Zucker rats, where induction of TGF-β1 and activation of hepatic stellate cells were abolished as well. 14 These observations are consistent with those of our present study. In our AngII infusion mouse model, atrial fibroblasts appear to play a key role in the promotion of profibrotic signals, similar to hepatic stellate cells in the liver. Interestingly, the above authors demonstrated that although the normal liver does not produce leptin, activated hepatic stellate cells produce leptin in vivo during fibrogenesis caused by thioacetamide. 14 This finding is also in agreement with our present observations that left-atrial tissue ( Figure 1A ) and atrial fibroblasts stimulated by AngII ( Figure 6 ) express abundant leptin. The same group recently demonstrated that hepatic fibrosis caused by thioacetamide does not develop in Ob mice. 11 A role for leptin signaling in macrophage infiltration has been reported in the kidney. 12 Tanaka et al 12 showed reduced renal macrophage infiltration after unilateral ureteral obstruction in Ob mice, a situation that was reversed by leptin administration. In the present study, we evaluated the transcript levels of F4/80, a marker of mature macrophages, as well as MCP-1 and RANTES, which are chemokines required for monocyte accumulation. We have recently demonstrated that expression of MCP-1 in the left atrium was enhanced A B by pressure overload via abdominal aortic constriction in rats, which was suppressed by pioglitazone. 15 Based on these findings, we concluded that MCP-1 is a key molecule in abdominal aortic constriction-induced inflammatory fibrotic processes in the left atrium, and that pioglitazone attenuates atrial fibrosis, possibly via suppression of MCP-1 expression. 15 Our current findings that the upregulation of F4/80, MCP-1, and RANTES witnessed in CNT mice and SD rat atrial fibroblasts is blocked by AngII in Ob mice and leptin in Zucker rat atrial fibroblasts also suggest that monocyte/ macrophage infiltration into left-atrial tissues is promoted by leptin signaling. Although limited studies have investigated the role of leptin in cardiac fibrosis, its hypertrophic effects have been demonstrated in experiments using cardiomyocytes. 16, 17 Rajapurohitam et al 16 initially reported that exposure of cultured neonatal rat ventricular myocytes to leptin for 24 hours produced cell hypertrophy, in association with enhanced expression of α-SMA and myosin light chain. Subsequently, the same group demonstrated that the hypertrophic effects of AngII on rat ventricular myocytes can be prevented by leptin antagonists. Because AngII caused a 5-fold increase in leptin in the culture medium, the authors concluded that leptin plays an autocrine role in mediating the hypertrophic effects of AngII. 17 These findings support our observation that AngII promotes leptin expression in CNT mice left atria and SD rat atrial fibroblasts, although it is unclear why AngII infusion results in decreased serum levels of leptin in CNT mice in vivo (Table) .
Ob mice develop morbid obesity and the characteristic hyperinsulinemia and hyperglycemia of type 2 diabetes mellitus by 8 weeks of age. 18, 19 In agreement, the serum levels of glucose and insulin were remarkably increased in the Ob mice at the start of the continuous AngII infusion (8 weeks old), as shown in the Table. Although we did not perform the analysis, the serum levels of triglycerides and free fatty acids are reportedly elevated in Ob mice. In addition, Ob mice heart rapidly modifies its energy metabolism, resulting in augmented fatty acid and decreased glucose consumption. 20 Thus, it remains to be elucidated whether our finding that Ob mice are resistant to atrial fibrosis by continuous AngII infusion is attributable to the direct effects of leptin or attributable to indirect metabolic changes characteristic to the mice. 21 On the other hand, leptin has been shown to regulate systemic immune responses, which may explain the lack of fibrotic responses to AngII in Ob mice and Zucker rat atrial fibroblasts. For instance, Gainsford et al 22 suggested that leptin regulates aspects of hemopoiesis and macrophage function. Santos-Alvarez et al 23 demonstrated that human leptin stimulates proliferation in a dose-dependent manner and functionally activates circulating monocytes in vitro by inducing the production of cytokines, such as tumor necrosis factor-α and interleukin-6. In fact, leptin-deficient mice are less prone to inflammatory diseases than nonleptin-deficient mice, including experimentally induced colitis, experimental autoimmune encephalomyelitis, type I diabetes mellitus, and experimentally induced hepatitis. 24 Attenuation of systemic immune responses in Ob mice may, in turn, reduce the development of atrial fibrosis evoked by AngII, as observed in the present study.
From the clinical viewpoint, the serum levels of leptin and AngII are elevated in patients with metabolic syndrome. 8, 25 In the Niigata preventive medicine study, 26 metabolic syndrome was shown to increase the risk of AF development. Our results may thus provide an explanation, at least partly, for why AF is developed more frequently in patients with metabolic syndrome and, additionally, support the use of leptin as a novel therapeutic target to prevent atrial fibrosis and AF in this population.
Conclusions
Our results demonstrate for the first time that leptin and its receptor-mediated signaling are fundamental to the pathogenesis of atrial fibrosis and AF evoked by AngII. Further studies are required to confirm the efficacy of leptin as a novel therapeutic target to prevent atrial fibrosis and AF in some populations, including those with metabolic syndrome.
